Ozempic may reduce liver cancer risk: new study
Ozempic, the diabetes drug currently enjoying widespread popularity as a weight loss aid and appetite supressant may also act as a preventive measure against certain kinds of cancer, new research finds. The trendy semaglutide injection, belonging to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists, was shown to reduce risks of liver cancer … Read more